Solanum melongena L. Extract Promotes Intestinal Tight Junction Re‐Assembly via SIRT‐1‐Dependent Mechanisms

Abstract Tight junction disruption can lead to pathogenesis of various diseases without therapeutic strategy to recover intestinal barrier integrity. The main objective of this study is to demonstrate the effect of Solanum melongena L . extract (SMLE) on intestinal tight junction recovery and its underlying mechanism. Intestinal barrier function is attenuated by Ca 2+ depletion. SMLE treatment increased TER value across T84 cell monolayers. Permeability assay reveals that Ca 2+ depletion promotes 4‐kDa FITC‐dextran permeability, but not 70‐kDa FITC‐dextran. SMLE suppresses the rate of 4‐kDa FITC‐dextran permeability, indicating that SMLE inhibits paracellular leak pathway permeability. SMLE‐mediated TER increase and leak pathway suppression are abolished by neither calcium/calmodulin‐dependent protein kinase kinase β (CaMKKβ) inhibitor nor AMP‐activated protein kinase (AMPK) inhibitor. Furthermore, mammalian target of rapamycin (mTOR) and extracellular signal‐regulated kinase (ERK) inhibitors have no effects on SMLE‐mediated TER increase and leak pathway suppression. Interestingly, SMLE is unable to enhance TER value and diminish leak pathway permeability in T84 cell monolayers pre‐treated with sirtuin‐1 (SIRT‐1) inhibitor. Immunofluorescence staining reveals that SMLE enhances re‐assembly of tight junction proteins, including occludin and ZO‐1 to intercellular space but this effect is abolished by SIRT‐1 inhibitor. These data suggest that SMLE promotes intestinal tight junction re‐assembly via SIRT‐1‐dependent manner.